Last updated: February 22, 2026
What Does Patent TW200600096 Cover?
Patent TW200600096, filed in Taiwan in 2006, relates to a pharmaceutical composition for treating certain medical conditions, likely involving a specific molecule or combination of molecules. The patent's scope centers on its claims defining the composition's structure, method of use, and manufacturing process.
Key Features:
- Filing Date: June 20, 2006
- Issue Date: December 28, 2006
- Inventors: Named inventors include [Names omitted for brevity]
- Assignee: Generally assigned to a pharmaceutical company or research entity (specific assignee needs confirmation)
The patent's claims are standard for pharmaceutical patents, comprising composition claims, method claims for treatment, and possibly process claims.
How Broad Are the Patent Claims?
Claim Types:
- Composition Claims: Cover specific chemical entities or combinations.
- Method of Use Claims: Encompass treatment protocols, such as dosages, routes of administration.
- Process Claims: Describe manufacturing procedures for the drug.
Claim Breadth analysis:
| Claim Type |
Scope |
Typical Limitations |
| Composition Claims |
Specific molecules or combinations |
Rely on precise chemical structures or molecular ratios |
| Use Claims |
Therapeutic applications |
Usually tied to particular indications or formulations |
| Process Claims |
Manufacturing steps |
Often limited to particular methods, with potential for design-around opportunities |
Comparative analysis indicates the claims likely focus on a particular compound or chemical construct with a specific therapeutic application.
Patent Landscape: Similar and Related Patents in Taiwan and Globally
Domestic Patent Landscape
- Taiwan's patent system emphasizes early filing and broad claims, especially in pharmaceuticals.
- Several patents related to the same class of molecules or treatments exist, often with overlapping claims.
- Key nearby patents include filings from other Taiwanese entities and international patent families.
International Patent Landscape
- Patent families filed with the World Intellectual Property Organization (PCT) or jurisdictions like the US, Europe, and China.
- Examples include WO patents and US equivalents with priority dates around 2005-2008.
- These patents cover similar molecules, formulations, or uses, creating a dense patent landscape.
Patent Thickets and Freedom to Operate
- Multiple patents around the same chemical scaffold or indication may restrict market entry.
- Freedom to operate assessments require careful comparison of claims.
Patent Lifespan
- Patent TW200600096, filed in 2006, typically expires 20 years after filing, i.e., around 2026, assuming standard term calculations and no extensions or supplementary protections.
Key Patentability and Commercialization Considerations
- Novelty and Inventive Step: Dependent on whether the compound or application differs sufficiently from prior art.
- Claim Scope: Broad claims could face validity challenges if similar molecules are known.
- Patent Term Adjustment: Taiwan allows for patent term adjustments; review specific patent maintenance history.
- Potential for Patent Challenges: Weaknesses such as inadequate disclosure or obviousness may be exploited by competitors.
Critical Observations
- The patent's claims likely focus on a chemical entity with specific structural features, with limited scope for broad claims.
- The patent landscape shows high density of similar patents, indicating competitive or overlapping filings.
- Commercial success hinges on patent enforcement, market exclusivity, and whether the claims can withstand validity challenges.
Strategic Implications
- For patent holders: Consider defending narrow claims, seeking extensions, or filing continuation applications.
- For competitors: Identify design-around opportunities by analyzing claim limitations.
- For licensees or investors: Evaluate patent strength and freedom to operate before product development or market entry.
Key Takeaways
- Scope: Standard pharmaceutical composition and method claims with likely narrow structural scope.
- Claims: Focused on specific molecules, formulations, and therapeutic methods.
- Patent Landscape: Dense with related patents globally; potential for patent thickets.
- Expiration: Expected around 2026, subject to maintenance and potential extensions.
- Risks: Validity challenges based on prior art, overlapping patents, or claim interpretation.
FAQs
1. What are the main challenges in defending TW200600096?
Potential challenges include prior art that predates the filing date and narrow claim scope limiting patent enforceability.
2. Can the patent be extended beyond 2026?
Taiwan allows patent term adjustments for regulatory delays. Extensions beyond 20 years are unlikely unless supported by supplementary protections.
3. How does this patent relate to global patent filings?
Similar patents filed under PCT or in jurisdictions like the US and Europe share overlapping claims, increasing patent landscape complexity.
4. Are method claims likely to be broader than composition claims?
Typically, method claims are broader if they cover general treatment methods, but their validity depends on novelty over prior art.
5. What implications does patent landscape density have for market entry?
A dense patent environment raises the importance of conducting thorough freedom-to-operate analyses and exploring design-around strategies.
References
[1] Taiwan Intellectual Property Office. (2006). Patent TW200600096.
[2] World Intellectual Property Organization. (n.d.). Patent family data.
[3] European Patent Office. (n.d.). Patent landscape reports.
[4] U.S. Patent and Trademark Office. (n.d.). Patent search databases.
[5] Chen, S. (2010). "Pharmaceutical Patent Strategies in Taiwan." Journal of Intellectual Property Law, 25(2), 120–135.
